Articles | Open Access | https://doi.org/10.55640/

EARLY DETERMINATION RISKS OF ATHEROSCLEROSIS IN THE PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE

Rasulova Z.D., Ibodulloev M.S. , Military Medical Institute of the Ministry of Defense of the Armed Forces of the Republic of Uzbekistan

Abstract

Metabolic associated fatty liver disease (MAFLD) is currently considered a widespread liver pathology in the world, and its presence is a significant risk factor for cardiovascular diseases. The main cause of death in patients with MAFLD is atherosclerotic cardiovascular diseases - heart attack and stroke. Therefore, early detection of subclinical atherosclerosis and timely prevention of cardiovascular complications in MAFLD is an urgent problem. The main attention is paid to military personnel, that is, the young and able-bodied population, as well as military personnel whose health condition affects the combat readiness of the army.

This article presents modern data on early markers of atherosclerotic processes in military personnel with MAFLD and methods for their assessment, mathematical indicators, and preventive measures. The novelties identified during the study provide recommendations for early detection of cardiovascular diseases among military personnel, improving their quality of life, reducing the incidence of liver pathology and treating them.

Keywords: Metabolic associated fatty liver disease (MAFLD), subclinical atherosclerosis, dyslipidemia, complex intima media (CIM), indices.

 

Keywords

x

References

x

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

EARLY DETERMINATION RISKS OF ATHEROSCLEROSIS IN THE PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE. (2025). International Journal of Medical Sciences, 5(12), 1019-1023. https://doi.org/10.55640/